Skip to main content
Clinical Trials/NCT03650309
NCT03650309
Completed
Not Applicable

Deep Brain Stimulation for the Treatment of Refractory Morbid Obesity

University Health Network, Toronto1 site in 1 country6 target enrollmentSeptember 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Obesity
Sponsor
University Health Network, Toronto
Enrollment
6
Locations
1
Primary Endpoint
Incidence of Treatment-Emergent Adverse Events
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is an open-label, phase I pilot trial designed to evaluate the safety and feasibility of deep brain stimulation (DBS) for the treatment of refractory morbid obesity. Patients with diagnoses of morbid obesity will be recruited and enrolled. All patients will receive DBS targeting two brains areas involved in the pathophysiology of obesity and will be followed post-operatively for 12 months.

Detailed Description

This study will establish 1)the safety of deep brain stimulation (DBS) in a patient population with treatment refractory morbid obesity. DBS has been used safely and effectively in thousands of patients for numerous disorders. Recent evidence (outlined above) has shown that DBS can also be used to manage refractory psychiatric conditions, such as depression and obsessive-compulsive disorder, as well as in eating disorders such as anorexia nervosa. Such studies indicate that a targeted therapy informed by the neuroanatomic and circuitry literature can be effective in altering pathological mood and behaviour. 2) evaluate the effectiveness of the procedure, which will be evaluated by the actual weight loss and resolution of the core symptoms of morbid obesity, including BMI, as well of, depression, self-esteem, and binge eating scores surrounding with loss or weight gain.

Registry
clinicaltrials.gov
Start Date
September 1, 2018
End Date
July 23, 2022
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Andres M. Lozano

Neurosurgeon, Professor of Surgery

University Health Network, Toronto

Eligibility Criteria

Inclusion Criteria

  • Female or Male patients between age 20-60
  • Diagnosis of Morbid Obesity (defined as a BMI\>40kg/m2 or BMI\>35 with 1 obesity related comorbidity) OR a diagnosis of Binge Eating Disorder not responsive to recommended treatments (as defined by the DSM-5)
  • Failure or non eligibility of bariatric surgery with \<50% of excess weight loss, with or without BMI\>35 kg/m2, at 18 months or more after the operation; OR diagnosis of binge eating disorder for over 18 months
  • Diagnosis of food dependence via Yale Food Addiction Scale (YFAS) criteria
  • Normal neurological exam
  • Normal head CT scan and cerebral MRI
  • Patient informed and able to give written consent
  • Able to comply with all testing, follow-ups and study appointments and protocols

Exclusion Criteria

  • Active neurologic disease such as epilepsy
  • Alcohol or substance dependence or abuse in the last 6 months, excluding caffeine and nicotine
  • Any contraindication to magnetic resonance imaging (MRI) or positron emission tomography (PET) scanning
  • Likely to relocate or move during the study's one year duration
  • Presence of cardiac arrhythmias, or other cardiac, respiratory, renal or endocrine conditions as a result of morbid obesity, that will result in significant risk from a surgical procedure.
  • Presence of epilepsy, stroke or degenerative disorder of the nervous system

Outcomes

Primary Outcomes

Incidence of Treatment-Emergent Adverse Events

Time Frame: 12 months

Patients will be closely monitored for adverse events following DBS surgery with regular check-ups.

Secondary Outcomes

  • Weight(12 months)
  • 'Quality of Life Scale' Questionnaire(12 months)
  • 'Generalized Anxiety Disorder 7-item (GAD-7)' Questionnaire(12 months)
  • 'Yale-Brown-Cornell Eating Disorder Scale (YBC-EDS)' Questionnaire(12 months)
  • 'Emotional Eating Scale (EES)' Questionnaire(12 months)
  • 'Eating Disorder Examination Questionnaire (EDE-Q)'(12 months)
  • 'Binge Eating Scale (BES)' Questionnaire(12 months)
  • 'Yale Food Addiction Scale (YFAS)' Questionnaire(12 months)
  • 'Difficulties in Emotion Regulation Scale (DERS)' Questionnaire(12 months)
  • 'Patient Health Questionnaire (PHQ-9)' Questionnaire(12 months)
  • 'Power of Food (POF)' Questionnaire(12 months)
  • 'Behavioral Inhibition System/Behavioral Activation System Scales (BIS/BAS Scales)' Questionnaire(12 months)
  • 'Yale-Brown Obsessive Compulsive Scale (Y-BOCS)' Questionnaire(12 months)

Study Sites (1)

Loading locations...

Similar Trials